Clinical Trials Browser

Phase 2 × HIV Seropositivity × Clear all

NCT03603808 2026-05-08

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Phase 2 Completed

44 enrolled 15 charts

Squamous Intraepithelial Lesions, HIV Seropositivity

NCT06919679 2025-04-09

BASTION

Phase 2 Not yet recruiting

HIV Seropositivity, Hodgkin Disease

NCT02029430 2024-06-11

A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

Phase 2 Completed

15 enrolled 9 charts

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Neoplasms, Sarcoma, Sarcoma, Kaposi

NCT01092182 2023-04-27

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

Phase 2 Completed

194 enrolled 19 charts

Plasmablastic Lymphoma, Burkitt Lymphoma, HIV Seropositivity, HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT01296113 2023-03-14

CHIVA

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, HIV Seropositivity